Background: psoriasis (Pso) is a prototype of Th1 proinflammatory cytokines mediated by an immunological
dysfunction. It is usually seen as inflammatory skin disease with far-reaching systemic consequences of uncertain
aetiology. There is increasing evidence of the seriousness of psoriatic skin disease as a significant danger of developing
outbreaks of extracutaneous diseases and of the greater frequency of co-morbid illness linked with cardiometabolic
dysfunction and Psoriatic Arthritis (PsA). Methods: 200 psoriatic patients were included in this research. Patients were
split into two groups depending on whether there was bursitis or not. Patients were tested and examined in history.
Results: Bursitis patients had a higher rate of psoriatic arthritis, enthesitis, heel condition, cardiovascular illness, serum
higher uric acid, longer duration of psoriasis disease than bursitis-free group. Conclusions: Longer duration of psoriasis,
leading to greater cardiovascular and musculoskeletal symptoms |
